Experiences of Stalking Victims and Requests for Help in Three European Countries. A Survey

Previous research by the Modena Group on Stalking (MGS) regarding awareness and recognition of stalking by police officers and general practitioners using case scenarios showed significant differences across three countries. It was also hypothesized that victims used different pathways when seeking help. To explore the experience of requesting help by victims of stalking in different European countries a detailed survey was completed by 391 victims of stalking in Belgium (n = 145), Italy (n = 126) and Slovenia (n = 120). The research confirmed the significant intensity and duration of stalking and psychological distress for victims. Victims used several pathways to survive stalking. Some victims reported that informal interventions they or family/friends implemented were effective, but the majority had to have recourse to helping agencies. Significant differences in help seeking behaviour were found between the three countries. In Belgium victims contacted the police, as well as other helping agencies, more often and more precociously than in Italy and Slovenia. Restriction orders against the stalker were considered the most effective intervention. Police were regarded as the least supportive agency, taking victims less seriously, and not being particularly effective at stopping the stalkers. Police were ranked after family/friends, lawyers and colleagues, with regards effectiveness, except in Belgium, where Police’s effectiveness was ranked second after lawyers. Stalking often requires the mobilization of multiple helping agencies by victims and it is important that victims are aware of what help is available to them and that agencies become more sensitive to their needs.     

Turkmenistan and the virtual politics of Eurasian energy: the case of the TAPI pipeline project

In December 2015, leaders from Central and South Asia took part in the ground-breaking ceremony for the Turkmenistan-Afghanistan-Pakistan-India (TAPI) natural gas pipeline project. Sixteen months later, a confusing information flow continues to obfuscate external assessments of the project’s development: official rhetoric notwithstanding, there is no certainty on the details of project financing, while the pipeline route has yet to be determined. To illuminate this obscure implementation path, this article regards TAPI as a virtual pipeline, an infrastructure project that wields invaluable influence only when it is employed as a foreign policy tool or permeates domestic discourses of progress framed by the elites of the four consortium partners. The constituent elements of TAPI virtuality are discussed here through a dedicated focus on the process of energy policy-making of Turkmenistan – the sole supplier of gas for the pipeline project and the consortium’s key stakeholder.     

Quality Standards in the Public Sector: Differences Between Italy and the UK in the Citizen's Charter initiative

Service quality of public services is a major aim of the New Public Management reforms occurring throughout Europe. The Citizen's Charter initiative, launched by the UK Prime Minister John Major in 1991, has been an example followed in some European countries, including Italy (Carta dei servizi). This paper analyses and evaluates the cultural differences in the usage of the concept of service quality standards between the UK experience and the Italian one, referring particularly to two kinds of public services, very different one from the other: healthcare and electricity supply. The comparative policy analysis leads to a sketch of two different profiles in the usage of quality standards in the public sector: a common law profile, where quality standards are not legal rights but targets to be achieved and improved; and a public law profile, where quality standards tend to be overlapped and confused with legal rights of users. Under the latter framework, standards are likely to be sidestepped because they are perceived more as a problem than as an opportunity to change.     

Homicides involving Black victims are less likely to be cleared in the United States

Does a victim's race explain variation in the likelihood of homicide clearance? Attempts to address this issue date back to the 1970s. Yet, despite its theoretical and policy relevance, we lack a comprehensive and clear empirical answer to this critical question. Here, I causally focus on this problem by investigating racial disparity in homicide clearance in the United States, exploiting two sources covering the 1991–2020 period: the Murder Accountability Project data set (N = 522,278) and the National Incident-Based Reporting System data set (N = 98,677). I primarily analyze these sources by employing exact matching to achieve perfect covariate balance and subsequently isolate the effect of race on the probability of clearance. For comparative purposes, I also use regression adjustment without matching obtaining complementary estimates. I demonstrate that the likelihood of clearance is 3.4 to 4.8 percent lower for homicides involving Black victims, depending on the sampling and estimation approach. In addition, I empirically show that this race effect is slightly higher for males and that racial disparity has moderately but significantly increased over time. These findings contribute to the extensive amount of evidence on discrimination affecting Black individuals in the administration of justice in the United States, calling for structural efforts to reduce this divide.     

Determination of blood/serum ratios of different forensically relevant analytes in authentic samples

For forensic toxicological investigations only whole blood, but no serum is often available. Pharmacokinetic data are helpful for interpreting the results, but most of these studies indicate serum or plasma concentrations. In order to obtain reliable conversion factors which also take intersubject variability into account, the blood/serum ratios (B/S) of oxycodone, morphine, fentanyl, hydromorphone, zopiclone, MDMA, dexamphetamine, alprazolam, risperidone and 9-hydroxyrisperidone were determined by LC-MS/MS using authentic samples. Blood and corresponding serum samples were obtained from driving studies performed with controlled or known dosages of the above drugs. The analytes were analysed in blood and serum and the following mean B/S ratios (relative standard deviations) were determined: oxycodone 1.48 (8.19 %); morphine 1.03 (3.59 %); fentanyl 0.87 (13.9 %); hydromorphone 1.04 (8.11 %); zopiclone 0.89 (16.1 %); MDMA 1.19 (8.04 %); dexamphetamine 0.89 (10.9 %); alprazolam 0.81 (5.84 %); risperidone 0.65 (7.52 %); 9-hydroxyrisperidone 0.73 (12.3 %). These mean values are largely in line with those reported in the literature. The B/S ratios did not appear to depend on partition coefficients, whereas there was strong evidence that B/S ratios decreased with increasing plasma protein binding.     

Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis

New Italian legislation on driving under the influence of drugs considers oral fluid (OF) as a possible alternative drug testing matrix. On this basis, the present research was carried out to evaluate the applicability of four commercial on-site OF drug screening devices, namely DDS(?), Drugtest 5000(?), Drugwipe 5+(?) and RapidSTAT(?), in a real operative context. Preliminarily trained police officers tested randomly stopped drivers with two different kits side-by-side during roadside patrols. A central laboratory confirmed on-site kits' results by UHPLC-MS/MS analysis of the saliva specimen remaining after the screening analysis. 1025 drivers were submitted to the OF tests: 11.6% were positive for cocaine and metabolites, 11.1% for THC, 6% for amphetamines and amphetamine-type designer drugs and 2.3% for ketamine. The sensitivities of the kits were 81% (RapidSTAT(?)), 82% (DDS(?)), 90% (Drugwipe 5+(?)) and 97% (Drugtest 5000(?)) for cocaine and 38% (DDS(?)), 47% (Drugwipe 5+(?)), 72% (RapidSTAT(?)) and 92% (Drugtest 5000(?)) for THC. Drugtest 5000 was the only kit showing an acceptable sensitivity for on-site application. Only Drugtest 5000(?) and RapidSTAT(?) could be evaluated for amphetamines and methamphetamines: Drugtest 5000(?) showed a sensitivity of 100% in the case of amphetamines and 86% for methamphetamines, while RapidSTAT(?) 90% and 76% respectively. Nowadays, ketamine is not included in the target analytes of any on-site devices, but it was systematically included in the UHPLC-MS/MS confirmatory analysis. To ensure adequate reliability, MS confirmation of on-site OF screening tests is anyway always necessary, due to the presence of a significant number of false positive results even when using the commercial kit with the best performance.